Positive Momentum in Metastatic Bladder Cancer: New Developments in Clinical Care

This CME-certified module was developed by Daniel P. Petrylak MD, to address important new changes in the treatment of bladder cancer. Topics include chemotherapy combinations, checkpoint inhibitors, and other targeted approaches in patients with advanced or metastatic urothelial carcinoma.
Daniel P. Petrylak, MD


Daniel P. Petrylak, MD, reviews current research on immunotherapies and provides his perspective on optimal management strategies for patients with bladder cancer.

Daniel P. Petrylak, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 6, 2016 Expired: July 5, 2017

In this downloadable slideset, Daniel P. Petrylak, MD, reviews key data and important changes to clinical practice in the management of advanced and metastatic urothelial carcinoma, including data presented at the 2016 American Society of Clinical Oncology Meeting.

Released: July 6, 2016
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by educational grants
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?